The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 351:1380-1383 September 30, 2004 Number 14
NextNext

Medical Marijuana, Physician-Assisted Suicide, and the Controlled Substances Act
Robert Steinbrook, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
The Controlled Substances Act is a 1970 law designed to prevent drug abuse and trafficking and to control the authorized distribution of narcotics, barbiturates, and other scheduled drugs. Nearly 35 years after its passage, the act is at the center of heated legal controversies about the medical use of marijuana and physician-assisted suicide. Cases related to both of these issues test the power of Attorney General John Ashcroft, the conservative former senator from Missouri, who is a long-standing opponent of both activities.

(Figure)

Figure Removed (Available Only in the Full Text)
View larger version (38K):
[in this window]
[in a new window]
 
 
States license physicians and regulate the practice of medicine; the federal government enforces drug laws. . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.